Satyamitra Kemas Lestari Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Satyamitra Kemas Lestari Tbk. trades at Rp138 (market cap 464.86B, 173K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 25.1× Satyamitra Kemas Lestari Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 173K). Which is the better fit depends on your goals.
| SMKL | TSPC | |
|---|---|---|
Market Cap | 464.86B | 11.68T |
Volume | 173K | 429.7K |
Lot | 1.73K | 4.3K |
Turnover | 23.72M | 1.11B |
Average Price | 137.1 | 2,591.65 |
Value | 23.72M | 1.11B |
Indicative Equilibrium Price | 138 | 2,580 |
Indicative Equilibrium Volume | 73 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Read more on SMKL →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →